About Vineet Laboratories Limited
Data last updated: 14 July 2026
Vineet Laboratories Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 10 November 2016, the company has been in operation for over 10 years.
Registered with ROC Hyderabad under CIN L24304TG2016PLC112888. Listed on BSE: 543298 and NSE: VINEETLAB.
Capital: an authorised share capital of ₹40 Cr and a paid-up capital of ₹19.21 Cr. It is led by directors including Gaddam Venkata Ramana and Satyanarayana Raju Bhupathiraju.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Hyderabad, Telangana.
As per NSE-filed standalone financials for FY 2025, the company reported a revenue of ₹75 Cr, a decline of 50.2% compared to the previous year. The net worth stands at ₹14.65 Cr (down 57.82% YoY). Total assets are valued at ₹94.54 Cr (down 19.11% YoY).
The company has a workforce of approximately 69 employees as per the latest available data.
The company is associated with 1 brand - Vineet Laboratories. As per MCA filings, the company has open charges of ₹45.08 Cr and satisfied charges of ₹28.34 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vineetlabs.co.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressSy.No. 11/A3 Saheb Nagar Kurdu Vill Chintal Kunta Eshwaramma Nilayam L B N, Agar, Hyderabad, Telangana, India – 500074
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Vineet Laboratories Limited
Vineet Laboratories Limited has one previous CIN (Corporate Identification Number): U24304TG2016PLC112888. The current CIN is L24304TG2016PLC112888, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24304TG2016PLC112888 | Current |
| U24304TG2016PLC112888 | Previous |
Associated Brands with Vineet Laboratories Limited
Vineet Laboratories Limited operates one associated brand: Vineet Laboratories. These brands represent Vineet Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| APIs are manufactured by Vineet Laboratories as a CDMO. | vineetlabs.co.in |
Competitors & Alternatives of Vineet Laboratories Limited
Brands and companies operating in the same space as Vineet Laboratories Limited include Inventys, Viyash, Blue Jet Healthcare and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Inventys
|
Actives, advanced intermediates, and specialty chemicals are custom manufactured. | Mumbai, India, India | 2005 |
Viyash
|
APIs and intermediates are manufactured by Viyash as a CDMO. | Hyderabad, India, India | 2019 |
Blue Jet Healthcare
|
CDMO focused on manufacturing, supplier, and development of intermediates & APIs | Mumbai, India, India | 1969 |
Ami organics
|
Advanced API intermediates are manufactured for pharmaceutical use. | Surat, India, India | 2007 |
Aparna Pharmaceuticals
|
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | Hyderabad, India, India | 2008 |
HuiSheng Biotech Pharmaceutical
|
APIs, intermediates, and finished dosage forms are manufactured. | Hangzhou, China, China | 2004 |
DUDE CHEM
|
CDMO focused on manufacturing of APIs and intermediates | Berlin, Germany, Germany | 2019 |
Enanti Labs
|
Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. | Hyderabad, India, India | 2007 |
Hindys Lab
|
Manufactures and exports pharmaceutical intermediates for global markets. | Hyderabad, India, India | 2007 |
Business Activity of Vineet Laboratories Limited
Vineet Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Vineet Laboratories Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Vineet Laboratories Limited
Vineet Laboratories Limited is audited by N V S R & Associates LLP (ICAI peer reviewed, certificate valid till 2026-06-30) for the financial year 2025, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| N V S R & Associates LLP (ICAI peer reviewed, certificate valid till 2026-06-30) | FY 2025 | Declaration of unmodified opinion |
Board of Directors of Vineet Laboratories Limited
Vineet Laboratories Limited is currently managed by 7 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Gaddam Venkata Ramana
Also directs:
Vineet Chem Trade Private Limited, Wohler Laboratories Private Limited, Vineet Life Sciences Limited and 1 more
|
Managing Director | 10 Nov 2016 | 9 Years 9 Months | Current |
|
Satyanarayana Raju Bhupathiraju
Also directs:
Vineet Life Sciences Limited
|
Whole-Time Director | 10 Nov 2016 | 9 Years 9 Months | Current |
| Dilip Vishnu Acharekar | Director | 16 Nov 2020 | 5 Years 9 Months | Current |
| Ranga Raju Alluri | Director | 12 Aug 2023 | 3 Years 0 Months | Current |
|
Jasmin Kunal Tailor
Also directs:
Stylesphere Collective Private Limited
|
Director | 09 Nov 2025 | 0 Years 9 Months | Current |
| Premananda Reddy Vennapusa | Director | 15 Sep 2025 | 0 Years 11 Months | Current |
Financials of Vineet Laboratories Limited FY 2025 filings available
Vineet Laboratories Limited reported revenue of ₹75 Cr (down 50.2% YoY) for FY 2025.
| Metrics | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹75 Cr | ₹150.59 Cr | ₹212.29 Cr | ₹191.17 Cr | ₹243.48 Cr |
| Other Income | ₹1.99 Cr | ₹46.32 Lakh | ₹12.3 Lakh | ₹28.51 Lakh | ₹38.6 Lakh |
| Total Income | ₹76.98 Cr | ₹151.05 Cr | ₹212.42 Cr | ₹191.46 Cr | ₹243.86 Cr |
| Cost of Materials Consumed | ₹63.77 Cr | ₹131.7 Cr | ₹168.1 Cr | ₹151.4 Cr | ₹192.76 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹6.47 Cr | -₹17.79 Cr | ₹4.23 Cr | -₹5.85 Cr | ₹5.36 Cr |
| Employee Benefit Expense | ₹5.34 Cr | ₹6.38 Cr | ₹6 Cr | ₹4.91 Cr | ₹5.57 Cr |
| Finance Costs | ₹3.98 Cr | ₹4.78 Cr | ₹3.38 Cr | ₹2.17 Cr | ₹2.67 Cr |
| Depreciation & Amortisation | ₹2.5 Cr | ₹2.52 Cr | ₹2.37 Cr | ₹2.02 Cr | ₹1.81 Cr |
| Other Expenses | ₹15.7 Cr | ₹23.09 Cr | ₹26.3 Cr | ₹27.47 Cr | ₹31.65 Cr |
| Total Expenses | ₹97.76 Cr | ₹150.69 Cr | ₹210.39 Cr | ₹182.11 Cr | ₹239.81 Cr |
| Profit Before Exceptional Items & Tax | -₹20.78 Cr | ₹36.34 Lakh | ₹2.03 Cr | ₹9.35 Cr | ₹4.06 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹20.78 Cr | ₹36.34 Lakh | ₹2.03 Cr | ₹9.35 Cr | ₹4.06 Cr |
| Total Tax Expense | -₹58.45 Lakh | -₹66.37 Lakh | ₹77.74 Lakh | ₹2.71 Cr | ₹2.28 Cr |
| Net Profit | -₹20.19 Cr | ₹1.03 Cr | ₹1.25 Cr | ₹6.64 Cr | ₹1.78 Cr |
| Other Comprehensive Income | ₹11.44 Lakh | ₹1.38 Lakh | ₹13.46 Lakh | -₹3.54 Lakh | ₹22.61 Lakh |
| Total Comprehensive Income | -₹20.08 Cr | ₹1.04 Cr | ₹1.39 Cr | ₹6.6 Cr | ₹2.01 Cr |
| EBITDA (computed) | -₹14.3 Cr | ₹7.66 Cr | ₹7.78 Cr | ₹13.53 Cr | ₹8.53 Cr |
| Basic EPS | ₹-21.90 | ₹1.11 | ₹1.36 | ₹7.16 | ₹2.18 |
| Diluted EPS | ₹-21.90 | ₹1.11 | ₹1.36 | ₹7.16 | ₹0.69 |
| Metrics | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Total Assets | ₹94.54 Cr | ₹116.87 Cr | ₹115.85 Cr |
| Non-current Assets | ₹27.15 Cr | ₹28.68 Cr | ₹28.39 Cr |
| Current Assets | ₹67.39 Cr | ₹88.19 Cr | ₹87.46 Cr |
| Property, Plant & Equipment | ₹25.46 Cr | ₹26.92 Cr | ₹26.65 Cr |
| Inventories | ₹49.97 Cr | ₹49.39 Cr | ₹46.17 Cr |
| Trade Receivables | ₹13.25 Cr | ₹31.6 Cr | ₹35.16 Cr |
| Cash & Equivalents | ₹30.67 Lakh | ₹22.78 Lakh | ₹63.07 Lakh |
| Equity (Net Worth) | ₹14.65 Cr | ₹34.72 Cr | ₹33.68 Cr |
| Equity Share Capital | ₹9.22 Cr | ₹9.22 Cr | ₹9.22 Cr |
| Borrowings (Non-current) | ₹3.79 Cr | ₹3.89 Cr | ₹4.85 Cr |
| Borrowings (Current) | ₹36.26 Cr | ₹40.41 Cr | ₹26.24 Cr |
| Total Debt (computed) | ₹40.05 Cr | ₹44.3 Cr | ₹31.09 Cr |
| Current Liabilities | ₹74.39 Cr | ₹76 Cr | ₹74.51 Cr |
| Total Liabilities | ₹79.89 Cr | ₹82.15 Cr | ₹82.17 Cr |
| Metrics | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating Cash Flow | ₹11.49 Cr | -₹11.43 Cr | -₹9.62 Cr | ₹7.71 Cr |
| Investing Cash Flow | -₹3.18 Cr | ₹33.26 Lakh | -₹6.69 Cr | -₹3.57 Cr |
| Financing Cash Flow | -₹8.23 Cr | ₹10.69 Cr | ₹27.31 Lakh | ₹11.87 Cr |
| Capital Expenditure | ₹1.05 Cr | ₹23.43 Lakh | ₹7.63 Cr | ₹3.73 Cr |
| Free Cash Flow (computed) | ₹10.45 Cr | -₹11.66 Cr | -₹17.25 Cr | ₹3.98 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹92.19 Lakh | ₹0 |
| Net Change in Cash | ₹7.9 Lakh | -₹40.3 Lakh | -₹16.03 Cr | ₹16.02 Cr |
| Metrics | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q4 FY23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹15.65 Cr | ₹17.42 Cr | ₹7.44 Cr | ₹14.08 Cr | ₹18.1 Cr | ₹18.96 Cr | ₹23.86 Cr | ₹37.05 Cr | ₹32.65 Cr | ₹43.37 Cr | ₹37.52 Cr | ₹57.2 Cr |
| Other Income | ₹4.76 Lakh | ₹84,000 | ₹1.81 Lakh | ₹1.38 Cr | ₹3.26 Lakh | ₹20.02 Lakh | ₹37.26 Lakh | ₹41.07 Lakh | ₹1.25 Lakh | ₹1.44 Lakh | ₹2.55 Lakh | ₹3.38 Lakh |
| Total Income | ₹15.7 Cr | ₹17.43 Cr | ₹7.46 Cr | ₹15.46 Cr | ₹18.13 Cr | ₹19.16 Cr | ₹24.23 Cr | ₹37.46 Cr | ₹32.66 Cr | ₹43.39 Cr | ₹37.55 Cr | ₹57.24 Cr |
| Cost of Materials Consumed | ₹9.72 Cr | ₹17.09 Cr | ₹12.01 Cr | ₹12.71 Cr | ₹18.07 Cr | ₹16.25 Cr | ₹16.74 Cr | ₹39.87 Cr | ₹29.78 Cr | ₹31.75 Cr | ₹30.3 Cr | ₹42.83 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹6.43 Lakh | -₹5.27 Cr | -₹7.4 Cr | ₹7.86 Cr | -₹79.94 Lakh | -₹2.82 Cr | ₹2.22 Cr | -₹13.47 Cr | -₹3.48 Cr | -₹1.31 Cr | ₹48.23 Lakh | -₹1.96 Cr |
| Employee Benefit Expense | ₹1.04 Cr | ₹79.65 Lakh | ₹1.06 Cr | ₹1.35 Cr | ₹1.21 Cr | ₹1.29 Cr | ₹1.48 Cr | ₹1.82 Cr | ₹1.77 Cr | ₹1.4 Cr | ₹1.4 Cr | ₹1.53 Cr |
| Finance Costs | ₹1.09 Cr | ₹2.19 Cr | ₹61.22 Lakh | ₹89.99 Lakh | ₹95.14 Lakh | ₹98.98 Lakh | ₹1.14 Cr | ₹1.72 Cr | ₹1.08 Cr | ₹1.02 Cr | ₹95.88 Lakh | ₹36.95 Lakh |
| Depreciation & Amortisation | ₹62.54 Lakh | ₹62.54 Lakh | ₹62.54 Lakh | ₹65.74 Lakh | ₹61.91 Lakh | ₹61.65 Lakh | ₹60.86 Lakh | ₹67.2 Lakh | ₹62.65 Lakh | ₹61.2 Lakh | ₹60.86 Lakh | ₹61.78 Lakh |
| Other Expenses | ₹2.34 Cr | ₹1.63 Cr | ₹1.45 Cr | ₹3.2 Cr | ₹3.75 Cr | ₹4.53 Cr | ₹4.22 Cr | ₹5.41 Cr | ₹5.22 Cr | ₹7.37 Cr | ₹5.08 Cr | ₹8.99 Cr |
| Total Expenses | ₹14.88 Cr | ₹17.06 Cr | ₹8.36 Cr | ₹26.68 Cr | ₹23.81 Cr | ₹20.87 Cr | ₹26.4 Cr | ₹36.03 Cr | ₹34.99 Cr | ₹40.84 Cr | ₹38.83 Cr | ₹52.38 Cr |
| Profit Before Exceptional Items & Tax | ₹81.8 Lakh | ₹37.16 Lakh | -₹90.16 Lakh | -₹11.22 Cr | -₹5.67 Cr | -₹1.71 Cr | -₹2.17 Cr | ₹1.43 Cr | -₹2.33 Cr | ₹2.54 Cr | -₹1.28 Cr | ₹4.85 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹81.8 Lakh | ₹37.16 Lakh | -₹90.16 Lakh | -₹11.22 Cr | -₹5.67 Cr | -₹1.71 Cr | -₹2.17 Cr | ₹1.43 Cr | -₹2.33 Cr | ₹2.54 Cr | -₹1.28 Cr | ₹4.85 Cr |
| Total Tax Expense | -₹3.27 Lakh | -₹2.94 Lakh | -₹3.55 Lakh | -₹69.62 Lakh | ₹3.3 Lakh | ₹11.57 Lakh | -₹3.7 Lakh | -₹49.03 Lakh | -₹26.65 Lakh | ₹12.54 Lakh | -₹3.23 Lakh | ₹1.3 Cr |
| Net Profit | ₹85.07 Lakh | ₹40.1 Lakh | -₹86.61 Lakh | -₹10.53 Cr | -₹5.71 Cr | -₹1.83 Cr | -₹2.13 Cr | ₹1.92 Cr | -₹2.07 Cr | ₹2.42 Cr | -₹1.25 Cr | ₹3.55 Cr |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹11.44 Lakh | ₹0 | ₹0 | ₹0 | ₹1.38 Lakh | ₹0 | ₹0 | ₹0 | ₹13.46 Lakh |
| Total Comprehensive Income | ₹85.07 Lakh | ₹40.1 Lakh | -₹86.61 Lakh | -₹10.41 Cr | -₹5.71 Cr | -₹1.83 Cr | -₹2.13 Cr | ₹1.94 Cr | -₹2.07 Cr | ₹2.42 Cr | -₹1.25 Cr | ₹3.68 Cr |
| EBITDA (computed) | ₹2.54 Cr | ₹3.18 Cr | ₹33.6 Lakh | -₹9.66 Cr | -₹4.1 Cr | -₹10.64 Lakh | -₹42.25 Lakh | ₹3.83 Cr | -₹62.9 Lakh | ₹4.18 Cr | ₹28.52 Lakh | ₹5.84 Cr |
| Basic EPS | ₹0.92 | ₹0.43 | ₹-0.94 | ₹-11.42 | ₹-6.19 | ₹-1.98 | ₹-2.31 | ₹2.09 | ₹-2.24 | ₹2.62 | ₹-1.36 | ₹3.85 |
| Diluted EPS | ₹0.92 | ₹0.43 | ₹0.00 | ₹-11.42 | ₹-6.19 | ₹-1.98 | ₹-2.31 | ₹2.09 | ₹-2.24 | ₹2.62 | ₹-1.36 | ₹3.85 |
Shareholding Pattern of Vineet Laboratories Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 5.98%, foreign institutional investors hold 0.36%, retail and other public shareholders hold 93.66% of Vineet Laboratories Limited. The company had 9,929 shareholders on record.
| Mar 2026 | Feb 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Promoters | 5.98% | 5.98% | 12.46% | 15.89% | 29.26% | 35.85% |
| Public | 94.02% | 94.02% | 87.54% | 84.11% | 70.74% | 64.15% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | |
|---|---|---|---|---|---|
| Promoters | 5.98% | 35.85% | 37.50% | 38.66% | 35.96% |
| Public | 94.02% | 64.15% | 62.50% | 61.34% | 64.04% |
| Promoter change (YoY, %pts) | -29.87 | -1.65 | -1.16 | +2.70 | - |
Charges & Borrowings of Vineet Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2022 | Hdfc Bank Limited | ₹44.9 Cr | Open |
| 01 Jan 2022 | Hdfc Bank Limited | ₹17.78 Lakh | Open |
| 25 Mar 2022 | Karnataka Bank Ltd. | ₹21.56 Lakh | Satisfied |
| 24 Mar 2022 | Karnataka Bank Ltd. | ₹28.12 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Vineet Laboratories Limited
Vineet Laboratories Limited has a workforce of 69 employees as of Apr 03, 2024.
Employee and EPFO history for Vineet Laboratories Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Vineet Laboratories Limited
GST registrations and filing compliance for Vineet Laboratories Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Vineet Laboratories Limited
Credit ratings, litigation, and regulatory alerts for Vineet Laboratories Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vineet Laboratories Limited
MSME payment history for Vineet Laboratories Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vineet Laboratories Limited
Corporate group structure for Vineet Laboratories Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vineet Laboratories Limited
MCA filings and documents for Vineet Laboratories Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Vineet Laboratories Limited
Frequently Asked Questions about Vineet Laboratories Limited
Vineet Laboratories Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 10 November 2016 (10+ years old) and is registered under CIN L24304TG2016PLC112888. Listed on BSE: 543298 and NSE: VINEETLAB. The company has 69 employees.
Vineet Laboratories Limited reported revenue of ₹75 Cr for FY 2025 (down 50.2% YoY) based on standalone NSE filings.
The current directors of Vineet Laboratories Limited are:
- Gaddam Venkata Ramana - Managing Director
- Satyanarayana Raju Bhupathiraju - Whole-Time Director
- Dilip Vishnu Acharekar - Director
- Ranga Raju Alluri - Director
- Jasmin Kunal Tailor - Director
- Premananda Reddy Vennapusa - Director
- Rajesh Kumar Kathulla - Additional Director
The primary industry of Vineet Laboratories Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Vineet Laboratories Limited is listed on both BSE (code: 543298) and NSE (symbol: VINEETLAB).
Vineet Laboratories Limited can be reached at the registered office: Sy.No. 11A3 Saheb Nagar Kurdu Vill Chintal Kunta Eshwaramma Nilayam L B N, Agar, Hyderabad, Telangana, India – 500074, or through the website vineetlabs.co.in.